Download PDF
Synlett 2010(5): 721-724  
DOI: 10.1055/s-0029-1219385
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Direct Synthesis of N-Aryl Derivatives of Quinazolin-4(3H)-ones Employing Arylboronic Acids in the Presence of Cu(OAc)2

Kintali Sreeramamurthy, Ettam Ashok, Velisoju Mahendar, Gourishetti Santoshkumar, Parthasarathi Das*
Discovery Research, Dr. Reddy’s Laboratories Ltd., Bollaram Road, Miyapur, Hyderabad 500049, AP, India
Fax: +91(40)23045438; e-Mail: parthads@yahoo.com;
Further Information

Publication History

Received 7 September 2009
Publication Date:
10 February 2010 (online)

    Permissions and Reprints All articles of this category

Abstract

Copper-promoted N-arylation of quinazolin-4(3H)-ones with boronic acid at room temperature in the presence of air has been investigated. This method is general and can be applied to synthesizing derivatives of quinazolin-4(3H)-one with medicinal values.

Key words

Cu(OAc)2 - boronic acid - quinazolin-4(3H)-one

    References and Notes

  • 1a Armarego WLF. Quinazolines   Brown DJ. John Wiley and Sons; London: 1967. 
    Google Scholar
  • 1b Ellis GP. Synthesis of Fused Heterocycles   Vol. 47:  John Wiley and Sons; Chichester: 1987. 
    Google Scholar
  • 1c Hermecz I. Kokosi J. Podanyi B. Szasz G. Heterocycles  1994,  37903 
    Google Scholar
  • 1d For review on quinazolinone, see: Mhaske SB. Argade NP. Tetrahedron  2006,  62:  9787 
    Google Scholar
  • 2 Fowler KW, Huang D, Kesicki EA, Ooi HC, Oliver AR, Ruan F, and Treiberg J. inventors; WO 2005113556, 2005-6, US  16778.  ; Chem. Abstr. 2006, 144, 22759
  • 3 Jiang JB. Hesson DP. Dusak BA. Dexter DL. Kang GJ. Hamel E. J. Med. Chem.  1990,  33:  1721 
    CrossrefGoogle Scholar
  • 4 Lowe JA. Archer RL. Chapin DS. Cheng JB. Helweg D. Johnson JL. Koe BK. Lebel LA. Moore PF. Nielsen JA. Russo LL. Shirley JT. J. Med. Chem.  1991,  34:  624 
    CrossrefGoogle Scholar
  • 5 Rudolph J. Esler WP. O’Connor S. Coish PDG. Wickens PL. Brands M. Bierer DE. Bloomquist BT. Bondar G. Chen L. Chuang C.-Y. Claus TH. Fathi Z. Fu W. Khire UR. Kristie JA. Liu X.-G. Lowe DB. McClure AC. Michels M. Ortiz AA. Ramsden PD. Schoenleber RW. Shelekhin TE. Vakalopoulos A. Tang W. Wang L. Yi L. Gardell SJ. Livingston JN. Sweet LJ. Bullock WH. J. Med. Chem.  2007,  50:  5202 
    CrossrefGoogle Scholar
  • 6a Katritzky AR. Rees CW. The Structure, Reaction, Synthesis and Uses of Heterocyclic Compounds, In Comprehensive Heterocyclic Chemistry   Part 2B, Vol. 3:  Pergamon Press; New York: 1984. 
    Google Scholar
  • 6b Pelletier SW. Alkaloids: Chemical and Biological Prospective   Vol. 1:  John Wiley and Sons; New York: 1983. 
    Google Scholar
  • 7 Takeuchi Y. Koike M. Azuma K. Nishioka H. Abe H. Kim H.-S. Wataya Y. Harayama T. Chem. Pharm.  2001,  49:  721 
    Google Scholar
  • 8a Tsantrizos YS. Xu X.-J. Can. J. Chem.  1993,  71:  1362 
    Google Scholar
  • 8b Wang H. Genesan A. J. Org. Chem.  1998,  63:  2432 
    Google Scholar
  • 8c He F. Snider BB. J. Org. Chem.  1999,  64:  1397 
    Google Scholar
  • 8d Sugimori T. Okawa T. Egushi S. Kakehi A. Yashima E. Okamoto Y. Tetrahedron  1998,  54:  7997 
    Google Scholar
  • 9a Kotsuki H. Sakai H. Morimoto H. Suenaga H. Synlett  1999,  1993 
    Google Scholar
  • 9b Khosropour AR. Mohammafpoor-Baltork I. Ghorbankhani H. Tetrahedron Lett.  2006,  47:  3561 
    Google Scholar
  • 9c Narasimhulu M. Mahesh KC. Reddy TS. Rajesh K. Venkateswarlu Y. Tetrahedron Lett.  2006,  47:  4381 
    Google Scholar
  • 10a Kametani T. Loc CV. Higa T. Koizumi M. Ihara M. Fukumoto K. J. Am. Chem. Soc.  1997,  99:  2306, 
    Google Scholar
  • 10b Connolly DJ. Guiry PJ. Synlett  2001,  1707 
    Google Scholar
  • 10c Wang L. Xia J. Qin F. Qin C. Sun J. Synthesis  2003,  1241 
    Google Scholar
  • 11 Salehi P. Dabiri M. Zolfigol MA. Bahgbanzadeh M. Tetrahedron Lett.  2004,  46:  7151 
    Google Scholar
  • 12 Xue S. McKenna J. Shieh WC. Repi O. J. Org. Chem.  2004,  69:  6474 
    CrossrefGoogle Scholar
  • 13 Shi D. Rong L. Wang J. Zhuang Q. Wang X. Hu H. Tetrahedron Lett.  2003,  44:  3199 
    CrossrefGoogle Scholar
  • 14a Kamal A. Reddy KS. Prasad BR. Babu AH. Ramana AV. Tetrahedron Lett.  2004,  45:  6-517  
    Google Scholar
  • 14b Kalusa A. Chessum N. Jones K. Tetrahedron Lett.  2008,  49:  5840 
    Google Scholar
  • 15a Chan DMT. Monaco KL. Wang R.-P. Winters MP. Tetrahedron Lett.  1998,  39:  2933 
    Google Scholar
  • 15b Lam PYS. Clark CG. Saubern S. Adams J. Winters MP. Chan DMT. Combs A. Tetrahedron Lett.  1998,  39:  2941 
    Google Scholar
  • 15c Chan DMT. Lam PYS. Recent Advances in Copper-Promoted C-Heteroatom Bond Cross-Coupling Reaction with Boronic Acids and Derivatives, In Boronic Acids: Preparation and Application in Organic Synthesis and Medicine   Hall DG. Wiley-VCH; Weinheim: 2005.  p.205 
    Google Scholar
  • 16a Lam PYS. Deudon S. Averil KM. Li R. He M. DeShong P. Clark CG. J. Am. Chem. Soc.  2000,  122:  7600 
    Google Scholar
  • 16b Lam PYS. Vincent G. Bonne D. Clark CG. Tetrahedron Lett.  2002,  43:  3091 
    Google Scholar
  • 16c Chan DMT. Monaco KL. Li R. Bonne D. Clark CG. Lam PYS. Tetrahedron Lett.  2003,  44:  3863 
    Google Scholar
  • 17a Evans DA. Katz JL. Peterson GS. Hinterman T. J. Am. Chem. Soc.  2001,  123:  12411 
    Google Scholar
  • 17b Collman JP. Zhong M. Zhang C. Costanzo S. Org. Lett.  2001,  66:  7892 
    Google Scholar
  • 17c Savarin C. Srogl J. Liebeskind LS. Org. Lett.  2002,  4:  4309 
    Google Scholar
  • 17d Bakkestuen AK. Gundersen L.-L. Tetrahedron Lett.  2003,  44:  3359 
    Google Scholar
  • 17e Strouse JJ. Jeselnik M. Tapaha F. Jonsson CB. Parker WB. Arterburn JB. Tetrahedron Lett.  2005,  46:  5699 
    Google Scholar
  • 17f Benard S. Neuville L. Zhu J. J. Org. Chem.  2008,  73:  6441 
    Google Scholar
  • 17g Guy CS. Jones TC. Synlett  2009,  2253 
    Google Scholar
  • 19 Ple PA. Green TP. Hennequin LF. Curwen J. Fennel M. Allen J. van der Brempt CL. Costello G. J. Med. Chem.  2004,  47:  871 
    CrossrefPubMedGoogle Scholar
18

General Procedure for N-Arylation of 4 (3 H )-Quinazolinone
A mixture of the requisite 4 (3H)-quinazolinone (1.0 mmol), phenylboronic acid (1.5 mmol), anhyd Cu(OAc)2 (1.0 mmol) and Et3N (2.0 mmol) in dry CH2Cl2 (10-15 mL) was stirred at ambient temperature under air for 24-70 h. Progress of the reaction was monitored by TLC. The reaction mixture was filtered through Celite, the filtrate concentrated in vacuo, and the resulting mixture purified by chromatography on silica gel (CH2Cl2-MeOH) to yield the corresponding N-substituted quinazolin-4 (3H)-one.
Selected Spectroscopic DataTable 1, Entry 6
Brown solid; mp 221-223 ˚C. IR (KBr): 3105, 3043, 2976, 2495, 1928 1614 cm-1. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.37 (s, 1 H), 8.14-8.12 (m, 1 H,), 7.95-7.93 (m, 1 H), 7.80-7.78 (m, 1 H), 7.62-7.60 (m, 2 H), 7.42-7.45 (m, 2 H). ¹³C NMR (50 MHz, CDCl3): δ = 159.0, 147.6, 146.4, 134.6, 131.6, 129.8, 129.6, 125.2, 116.2, 115.7. ESI-MS: 275 [M + H]+. ESI-HRMS: m/z calcd for C14H9ClFN2O [M + H]+: 275.0387; found: 275.0383.
Table 1, Entry 7
Brown solid; mp 194-196 ˚C. IR (KBr): 3066, 2981, 2939, 2727, 1681, 1556 cm-¹. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.32 (s, 1 H), 8.17-8.15 (m, 1 H), 7.97-7.95 (m, 1 H) 7.76-7.73 (m, 1 H), 7.12-7.10 (m, 1 H), 7.03-6.98 (m, 2 H), 4.30 (s, 4 H). ¹³C NMR (50 MHz, CDCl3): δ = 159.0, 147.7, 146.3, 143.7, 143.2, 134.5, 131.4, 130.2, 129.4, 125.2, 123.1, 120.1, 117.0, 116.3, 64.0. ESI-MS: 315 [M + H]+. ESI-HRMS): m/z calcd for C16H12ClN2O3 [M + H]+: 315.0536; found: 315.0529.
Table 1, Entry 8
Brown solid; mp 190-192 ˚C. IR (KBr): 3086, 3026, 2962, 2654, 1739, 1610 cm-¹. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.24 (s, 1 H), 7.58-7.48 (m, 6 H,), 7.20-7.18 (m, 1 H), 3.94 (s, 3 H), 3.89 (s, 3 H). ¹³C NMR (50 MHz, CDCl3): δ = 159.2, 154.6, 148.9, 145.6, 143.8, 137.7, 129.1, 128.5, 127.4, 114.8, 108.0, 105.4, 56.0, 55.7. ESI-MS: m/z = 283 [M + H]+. ESI-HRMS: m/z calcd for C16H15N2O3 [M + H]+: 283.1083; found: 283.1081.
Table 1, Entry 9
Brown solid; mp 243-245 ˚C. IR (KBr): 3433, 3060, 2962, 2837, 1683, 1610, 1502 cm-¹. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.22 (s, 1 H), 7.49-7.47 (m, 1 H), 7.46-7.44 (m, 1 H), 7.39-7.37 (m, 2 H), 7.19-7.17 (m, 1 H), 3.94 (s, 3 H), 3.88 (s, 3 H), 2.30 (s, 3 H). ¹³C NMR (50 MHz, CDCl3): δ = 161.4, 159.2, 154.68, 148.99, 145.64, 143.84, 133.65, 130.68, 126.9, 125.3, 115.6, 114.7, 108.0, 105.3, 56.02, 55.75, 14.07. ESI-MS: m/z 315 [M + H]+. ESI-HRMS: m/z calcd for C17H16FN2O3 [M + H]+: 315.1145; found: 315.1143.

20

Selected Spectroscopic DataTable 2, Entry 2
Brown solid; mp 125-127 ˚C. IR (KBr): 3429, 3076, 2954, 2495, 2854 2445, 1678 cm-¹. ¹H NMR (400 MHz, DMSO-d 6): δ = 8.22 (s, 1 H), 7.60-7.58 (m, 2 H,), 7.56-7.54 (m, 1 H), 7.40-7.36 (m, 2 H), 7.20-7.18 (m, 1 H), 4.20-4.18 (m, 2 H), 3.85 (s, 3 H), 3.60-3.58 (m, 4 H), 2.46-2.38 (m, 6 H), 1.96-1.94 (m, 2 H). ¹³C NMR (50 MHz, CDCl3): δ = 164.0, 159.0, 153.9, 149.0, 145.5, 143.7,134.0, 133.8, 129.7, 129.5, 116.0, 115.6, 114.6, 108.6, 105.5, 66.9, 64.8, 55.7, 54.6, 53.0, 25.4. ESI-MS: 414 [M + H]+. ESI-HRMS: m/z calcd for C22H25FN3O4 [M + H]+: 414.1829; found: 414.1830.